To evaluate the role of IL-33/ST2 signaling on CD4+ FOXP3+ Tregs for intestinal tumorigenesis, we treated C57BL/6 wild-type (WT) and St2−/− mice with AOM and DSS. This evidence concerns the gene CD4 and infectious otitis media.